NCT04827914

Brief Summary

The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion). The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,122

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Mar 2021Sep 2026

Study Start

First participant enrolled

March 8, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 30, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 6, 2025

Status Verified

April 1, 2025

Enrollment Period

5.5 years

First QC Date

March 30, 2021

Last Update Submit

April 3, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Self-reported smoking prevalence 6-weeks after hospitalization.

    Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2-fold higher 7-day non-smoker prevalence rate after hospitalization (i.e., 20% vs 10%)

    Assessed 6-weeks post-discharge

  • Self-reported use of FDA Approved Smoking Cessation Medication

    Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2.5-fold greater use of an FDA approved stop smoking medication after hospitalization (i.e., 20% vs 8%)

    Assessed 6-weeks post-discharge

Study Arms (2)

Enhanced Care Condition

EXPERIMENTAL
Behavioral: Enhanced Care

Basic Care Condition

ACTIVE COMPARATOR
Behavioral: Basic Care

Interventions

Enhanced CareBEHAVIORAL

Smokers in the enhanced care group will receive live counseling (either in person or telehealth consult) while hospitalized combined with post-hospital discharge automated calls using interactive voice recognition (IVR) technology.

Enhanced Care Condition
Basic CareBEHAVIORAL

Smokers assigned to the basic care group will only receive the post-discharge IVR phone calls.

Basic Care Condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • + years and older
  • hospitalized cigarette smokers eligible for either enhanced or basic care
  • discharged from the hospital back to their home

You may not qualify if:

  • patients without a phone number
  • those unable to communicate in the English language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Institute of Psychiatry

Charleston, South Carolina, 29425, United States

Location

MUSC

Charleston, South Carolina, 29425, United States

Location

MUSC

Chester, South Carolina, 29706, United States

Location

MUSC

Florence, South Carolina, 29505, United States

Location

MUSC

Lancaster, South Carolina, 29720, United States

Location

MUSC

Marion, South Carolina, 29574, United States

Location

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Study Officials

  • Kenneth M Cummings, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2021

First Posted

April 1, 2021

Study Start

March 8, 2021

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 6, 2025

Record last verified: 2025-04

Locations